Gene · 8301
Papers2,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plasma proteomics-based biomarkers for predicting response to mesenchymal stem cell therapy in severe COVID-19. | Stem Cell Res Ther | 2023 | 38072927 | PubTator, text mining | PubMed |
| Beta-2 adrenergic receptor agonism alters astrocyte phagocytic activity and has potential applications to psychiatric disease. | Discov Ment Health | 2023 | 38036718 | PubTator, text mining | PubMed |
| Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease. | Nat Commun | 2023 | 38036535 | PubTator, text mining | PubMed |
| Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease. | Front Neurosci | 2023 | 38033541 | PubTator, text mining | PubMed |
| Molecular genetics of neuropsychiatric illness: some musings. | Front Genet | 2023 | 38028602 | PubTator, text mining | PubMed |
| Computational analysis of five neurodegenerative diseases reveals shared and specific genetic loci. | Comput Struct Biotechnol J | 2023 | 38022694 | PubTator, text mining | PubMed |
| PICALM Variation Moderates the Relationships of APOE ɛ4 with Alzheimer's Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population. | J Alzheimers Dis | 2023 | 38007652 | PubTator, text mining | PubMed |
| Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies. | Int J Mol Sci | 2023 | 38003477 | PubTator, text mining | PubMed |
| Alzheimer's genes in microglia: a risk worth investigating. | Mol Neurodegener | 2023 | 37986179 | PubTator, text mining | PubMed |
| Protocol to study human mitochondrial ribosome using quantitative density gradient analysis by mass spectrometry and complexome profiling analysis. | STAR Protoc | 2023 | 37976156 | PubTator, text mining | PubMed |
| Targeting autophagy in Alzheimer's disease: Animal models and mechanisms. | Zool Res | 2023 | 37963840 | PubTator, text mining | PubMed |
| Organ-Specificity of Breast Cancer Metastasis. | Int J Mol Sci | 2023 | 37958607 | PubTator, text mining | PubMed |
| Simple model systems reveal conserved mechanisms of Alzheimer's disease and related tauopathies. | Mol Neurodegener | 2023 | 37950311 | PubTator, text mining | PubMed |
| Subvalvular Aortic Stenosis: Learning From Human and Canine Clinical Research. | Cardiol Res | 2023 | 37936623 | PubTator, text mining | PubMed |
| The relationship between Alzheimer disease and thyroiditis: A two-sample Mendelian randomization study. | Medicine (Baltimore) | 2023 | 37933065 | PubTator, text mining | PubMed |
| Alternative splicing of IRF3 plays an important role in the development of hepatocarcinoma. | Epigenetics | 2023 | 37926963 | PubTator, text mining | PubMed |
| Dissecting the human leptomeninges at single-cell resolution. | Nat Commun | 2023 | 37923721 | PubTator, text mining | PubMed |
| Integration of multiple-omics data to reveal the shared genetic architecture of educational attainment, intelligence, cognitive performance, and Alzheimer's disease. | Front Genet | 2023 | 37900179 | PubTator, text mining | PubMed |
| Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis. | Int J Mol Sci | 2023 | 37895120 | PubTator, text mining | PubMed |
| Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders. | Biomedicines | 2023 | 37893165 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8301/papers?page=7